AtaCor Subcostal Temporary Extravascular Pacing III Study

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 3, 2020

Primary Completion Date

January 25, 2022

Study Completion Date

May 11, 2022

Conditions
Conduction Defect
Interventions
DEVICE

AtaCor StealthTrac Lead

Subjects are assigned non-randomly to receive one of the four AtaCor StealthTrac leads being evaluated in the study.

Trial Locations (4)

Unknown

Na Homolce Hospital, Prague

Christchurch Hospital, Christchurch

Wellington Regional Hospital, Wellington

Sanatorio Italiano, Asunción

Sponsors
All Listed Sponsors
lead

AtaCor Medical, Inc.

INDUSTRY

NCT04538287 - AtaCor Subcostal Temporary Extravascular Pacing III Study | Biotech Hunter | Biotech Hunter